IntuitionLabs

Pharmaceutical Industry Articles & Reports - Page 19

Articles (Page 19)

Browse by Tags
Measuring AI ROI in Drug Discovery: Key Metrics & Outcomes
Measuring AI ROI in Drug Discovery: Key Metrics & Outcomes

Learn how to measure AI ROI in drug discovery beyond cost and time savings. Updated for 2026 with 173+ AI clinical programs, Insilico's Phase IIa results, Recursion-Exscientia merger, and new FDA guidance. Key metrics for scientific outcomes, pipeline productivity, and commercial value.

45 min read
12/8/2025
AI for Biotech: A Build vs. Buy Decision Framework
AI for Biotech: A Build vs. Buy Decision Framework

A framework for biotech CDOs on the build vs. buy AI decision. Analyzes costs, time-to-value, integration challenges, vendor evaluation criteria, and the emerging foundation model licensing trend. Updated April 2026 with EU AI Act compliance deadlines, FDA-EMA joint guidance, and latest pharma AI partnerships.

40 min read
12/8/2025
Algorithmic Redlining: How AI Bias Works & How to Stop It
Algorithmic Redlining: How AI Bias Works & How to Stop It

Understand algorithmic redlining, a form of AI bias creating housing and lending discrimination. Explore its causes, legal frameworks including the EU AI Act and state enforcement, and effective technical solutions. Updated with 2025-2026 enforcement actions, CFPB changes, and Colorado AI Act developments.

50 min read
12/4/2025
CLM for Life Sciences: Using AI to Move Beyond Spreadsheets
CLM for Life Sciences: Using AI to Move Beyond Spreadsheets

Learn why spreadsheets fail for life sciences contract management. This guide explores how AI-powered CLM platforms — including agentic AI tools like Icertis Vera — improve efficiency, compliance, and clinical trial cycle times. Updated for 2026 with EU AI Act enforcement, FDA/EMA joint AI principles, and the latest Gartner Magic Quadrant CLM leaders.

40 min read
12/4/2025
Showing 433-456 of 961 articles

© 2026 IntuitionLabs. All rights reserved.